Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
16%
OVERLAP
BY WEIGHT
23
# OF OVERLAPPING
HOLDINGS
XBI
116
HOLDINGS
20%
ALSO IN IDNA
IDNA
44
HOLDINGS
61%
ALSO IN XBI
SECTOR DRIFT (XBI minus IDNA)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in IDNA |
Overlap | |
|---|---|---|---|---|
 |
INCYTE CORP | 2.7% | 4.7% | 2.7% |
|
REGENERON PHARMACEUTICALS | 2.4% | 4.5% | 2.4% |
|
EXELIXIS INC | 2.1% | 3.6% | 2.1% |
|
MODERNA, INC. | 1.9% | 3.4% | 1.9% |
|
REVOLUTION MEDICINES, INC. | 1.6% | 4.5% | 1.6% |
XBI Overweight Relative to IDNA
|
ALNYLAM PHARMACEUTICALS INC | 3.5% |
|
INSMED INC | 3.3% |
|
UNITED THERAPEUTICS CORP | 3.3% |
|
HALOZYME THERAPEUTICS INC | 3.2% |
|
NEUROCRINE BIOSCIENCES INC | 2.5% |
|
ABBVIE INC | 2.5% |
|
MADRIGAL PHARMACEUTICALS, INC. | 2.5% |
|
BIOGEN IDEC INC | 2.4% |
|
BRIDGEBIO PHARMA, INC. | 2.3% |
|
GILEAD SCIENCES INC | 2.3% |
XBI Underweight Relative to IDNA
 |
GENMAB A/S | -5.0% |
 |
ASTRAZENECA PLC | -4.3% |
|
MERCK & CO. INC. | -4.1% |
 |
TAKEDA PHARMACEUTICAL CO LTD | -4.0% |
 |
ROCHE HOLDING LTD | -4.0% |
|
GSK PLC | -3.9% |
|
CELCUITY INC. | -3.8% |
 |
SANOFI-AVENTIS | -3.7% |
 |
BIONTECH SE SPONSORED ADR | -3.5% |
|
ARCELLX, INC. | -3.4% |